ANDERS TUV
Chief Investment Officer
anders@radforsk.no
+47 98206826
Anders is an experienced investment and business development professional with broad experience from the life science industry covering management positions, strategy and business development, research collaborations, licensing deals, M&A and IPOs.
He is currently Chairman of the Board Vaccibody, Non-executive director Photocure ASA, Non-executive director Zelluna Immunotherapy, Non-executive director Nextera, Non-executive director NucliGen, member of the Nomination Committee of PCI Biotech ASA. He also holds several advisory roles.
JÓNAS EINARSSON
CEO
jonas@radforsk.no
+47 48096355
Einarsson has for the last 16 years acted as the CEO for RADFORSK. During this time, he has transferred RADFORSK from being a Technology Tech Transfer Office for the Norwegian Radium Hospital, to one of the most successful preseed investors in Europe with focus on startup companies based on Norwegian research within immunoncology.
Einarsson is also the founder and former CEO and Chairman of the board, of Oslo Cancer Cluster and the Oslo Cancer Cluster Innovation Park. Hei is today acting as senior adviser for Oslo Cancer Cluster and as a member of the board of the Innovation Park.
Before joining RADFORSK, Einarsson was the CEO and Chairman of the board of Norway’s first private hospital, Oslo Private Sykehus AS, and he acted as GP and Chief Medical Officer of Lærdal Municipality for ten years.
BENTE PRESTEGÅRD
Senior Advisor
bp@radforsk.no
+47 41308175
Bente Prestegård is senior advisor in RADFORSK. She has long experience from the formalization of collaboration agreements and licensing between Oslo University Hospital and the pharmaceutical industry.
Bente has a background from business administration and as a pharmaceutical sales representative.